Results 21 to 30 of about 350,534 (292)

Intramuscular hemangiom

open access: yesTurkish Archives of Otorhinolaryngology, 2012
Hemangiom are vascular formations in the body and develop from any site. Hemangiomas originate from skeletal muscle accounts for less than 1% of all hemangiomas. Skeletal muscle hemangiomas are seen rarely so that difficult to diagnose.
Remzi Doğan   +2 more
doaj   +1 more source

Simultaneous bifocal and asymptomatic intramuscular nodular fasciitis of the thigh: A case report

open access: yesClinical Case Reports, 2020
Nodular fasciitis (NF) is a rapid‐growth benign that is misdiagnosed as sarcoma and leads to overtreatment. The spontaneous regression of NF is a possible phenomenon. “Wait and see” ideal is one of the treatment strategies of NF.
Sermsak Sukpanichyingyong   +8 more
doaj   +1 more source

The action of obestatin in skeletal muscle repair: stem cell expansion, muscle growth, and microenvironment remodeling [PDF]

open access: yes, 2015
The development of therapeutic strategies for skeletal muscle diseases, such as physical injuries and myopathies, depends on the knowledge of regulatory signals that control the myogenic process. The obestatin/GPR39 system operates as an autocrine signal
ADAMO, Sergio   +16 more
core   +1 more source

A retrospective review of intramuscular olanzapine and parenteral benzodiazepine coadministration in the emergency department [PDF]

open access: yesMental Health Clinician
Introduction Acute agitation is a common presenting symptom in medical and mental health emergencies that may require pharmacologic intervention. There is a manufacturer recommendation against intramuscular coadministration of olanzapine with parenteral (
Jessica Laub, PharmD, BCEMP   +3 more
doaj   +1 more source

Safety and efficacy of a propofol and ketamine based procedural sedation protocol in children with cerebral palsy undergoing botulinum toxin A injections. [PDF]

open access: yes, 2019
Background Pediatric patients with cerebral palsy (CP) often undergo intramuscular botulinum toxin (BoNT‐A) injections. These injections can be painful and may require procedural sedation.
Abu-Sultaneh, Samer   +4 more
core   +1 more source

Passive immunization against Histomonas meleagridis does not protect turkeys from an experimental infection [PDF]

open access: yes, 2009
Histomonosis or blackhead is a disease of gallinaceous birds, caused by the protozoan Histomonas meleagridis. As recent regulatory action has removed almost all drugs against this disease from the European market, the development of new prophylactics has
Bleyen, Nele   +3 more
core   +4 more sources

Study of a 13-weeks, Repeated, Intramuscular Dose, Toxicity Test of Sweet Bee Venom in Sprague-Dawley Rats

open access: yesJournal of Pharmacopuncture, 2014
Objectives:This study was performed to analyze a 13-week repeated dose toxicity test of Sweet Bee Venom (SBV) extracted from bee venom and administered in Sprague-Dawley (SD) rats.
Hyunmin Kang   +3 more
doaj   +1 more source

Epinephrine in Anaphylaxis: Preclinical Study of Pharmacokinetics after Sublingual Administration of Taste-Masked Tablets for Potential Pediatric Use

open access: yesPharmaceutics, 2018
Epinephrine is a life-saving treatment in anaphylaxis. In community settings, a first-aid dose of epinephrine is injected from an auto-injector (EAI). Needle phobia highly contributes to EAI underuse, leading to fatalities—especially in children. A novel
Ousama Rachid   +2 more
doaj   +1 more source

Posterior Cervical Intramuscular Schwannoma Within the Trapezius Muscle: A Case Report

open access: yesTurkish Archives of Otorhinolaryngology, 2022
Schwannomas are benign soft tissue tumors derived from the Schwann cells of the peripheral nerves. An intramuscular schwannoma arising within the trapezius muscle in the posterior neck is rare.
Naoto Koike   +3 more
doaj   +1 more source

MPLA and AddaVax® Adjuvants Fail to Promote Intramuscular LaAg Vaccine Protectiveness against Experimental Cutaneous Leishmaniasis

open access: yesMicroorganisms, 2021
There is so far no vaccine approved for human leishmaniasis, mainly because of the lack of appropriate adjuvants. This study aimed to evaluate in mice the capacity of a mixture of monophosphoryl lipid A (MPLA) and AddaVax® adjuvants in enhancing the ...
Diogo Oliveira-Maciel   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy